CN Stock MarketDetailed Quotes

600812 North China Pharmaceutical

Watchlist
  • 5.34
  • +0.06+1.14%
Market Closed Dec 27 15:00 CST
9.16BMarket Cap116.09P/E (TTM)

About North China Pharmaceutical Company

The company's predecessor, the North China Pharmaceutical Factory, was a key construction project during China's “First Five-Year Plan”. Preparation began in June 1953, and was completed and put into operation in June 1958. It pioneered the history of large-scale antibiotic production in China, and made important contributions to the cause of human health, the development of the national pharmaceutical industry, and the shortage of medicines in China. The company was restructured in 1992 and listed on the Shanghai Stock Exchange in 1994. It is mainly engaged in R&D, production and sales of pharmaceutical products. The company's products cover the fields of chemical pharmaceuticals, modern biotechnological drugs, vitamins and health consumer products, biological pesticides and veterinary drugs, etc., covering more than 700 products such as anti-infective drugs, biotechnological drugs, cardiovascular and immunomodulators, vitamins and health consumer products. Corporate honors: 2017 - North China Pharmaceutical Group won the top ten export companies in China's Western Pharmaceutical Industry, 2016 - North China Pharmaceutical Group won the top ten pharmaceutical industry enterprises in Hebei Province, 2016 - North China Pharmaceutical Group won the top ten pharmaceutical industry enterprises in Hebei Province, 2014 - won the top 100 comprehensive strength industrial enterprises in China's chemical pharmaceutical industry, etc.

Company Profile

Short Name-A华北制药
Symbol-A600812
Company NameNORTH CHINA PHARMACEUTICAL COMPANY. LTD
Listing DateJan 14, 1994
Issue Price4.00
Shares Offered70.00M share(s)
FoundedDec 20, 1992
Listed ExchangeSH Stock Exchange
Legal Representativelixin wang
General Managerlixin wang
Secretaryzhiguang xiao
Accounting FirmLianda Certified Public Accountants (Special General Partnership)
Securities Representativejing yang
Legal CounselBeijing Deheng Law Firm
Employees3720
Phone0311-87173756
Office AddressNo. 388, Heping East Road, Shijiazhuang, Hebei
Zip Code050015
Registered AddressNo. 388, Heping East Road, Shijiazhuang, Hebei
Fax0311-86060942
Emailxiaozhiguang@ncpc.com
Business License130000000008365
BusinessProduction and sale of pharmaceuticals (operating in accordance with the scope and expiration date of license approval); production and sale of Chinese medicine tablets (operating in accordance with the scope and expiration date of license approval); production and sale of pharmaceutical intermediates, plant extracts, and food additives; storage of goods (except those prohibited or subject to approval by laws, regulations, or decisions of the State Council); general freight; import and export business of commodities and technology, with the exception of goods and technologies operated by national companies or prohibited from being imported and exported; pharmaceutical and chemical technology transfer, technology development, technical consulting services; machinery and equipment cleaning, electromechanical equipment installation, inspection and inspection of food; , packaging materials, cosmetics, office supplies, labor insurance supplies, daily necessities, clothing, construction materials, communication equipment, electronic products, plastic and rubber products, auto parts, office furniture, lubricants, hardware, instruments, medicinal glass products, chemical reagents, mechanical equipment, electrical machinery and spare parts (except those requiring prior approval); sales of hygiene products; housing rental; the following are limited to branch operations (license operation involving licensing): pharmaceutical excipients (recombinant human blood albumin), suppositories, tinctures Powders, hollow capsules, mixtures, drops, oral Production of liquids and solutions; production and sale of recombinant human blood albumin (non-blood products, non-pharmaceuticals); veterinary drug sales; wholesale of proprietary Chinese medicines, chemical raw materials and their preparations, biochemicals, biological products, and second-class psychotropic drug preparations; sales of disinfectants and medical devices; sale of family planning supplies (except pharmaceuticals and medical devices requiring approval), health products, pharmaceutical intermediates, plant extracts retail; pharmaceutical glass bottles, daily use glass products, and industrial oxygen; production of pharmaceutical glass bottles, daily use glass products, and industrial oxygen Products, steel and its products, aluminum and its products, paper, non-ferrous metals , wholesale and retail of coke; R&D and technical consulting of traditional Chinese medicine products, Chinese and Western medicine, biotechnology products, agroveterinary medicine and comprehensive technology; production and sales of cats in the general environment (operated with an “Experimental Animal Production License”) drug inspection services; R&D, processing, production and sales of prepackaged food, health food, and formula for special medical purposes. Production and sale of raw materials for cosmetics and sanitary dressings; research and development, production, sales and technical consulting of biological products (projects subject to approval according to law can only be carried out after approval by relevant departments).

Company Executives

  • Name
  • Position
  • Salary
  • lixin wang
  • Chairman, directors, general manager, Chairman of the Strategy (Investment Decision) Committee, Member of the Nomination and Remuneration Assessment Committee
  • 706.90K
  • rentao song
  • Directors
  • --
  • yao cao
  • Directors, Audit Committee Members
  • 200.40K
  • yalou wang
  • Directors, Member of the Nomination and Remuneration Assessment Committee
  • 215.30K
  • xiujun wang
  • Directors
  • --
  • zhiguang xiao
  • directors, Board Secretary, Head of finance, chief accountant, Member of the Strategy (Investment Decision) Committee
  • --
  • yingzhe shi
  • Independent directors, Chairman of the Nomination and Remuneration Committee, Member of the Related Transactions Review Committee, Member of the Strategy (Investment Decision) Committee, Audit Committee Member
  • --
  • demin zhou
  • Independent directors, Member of the Related Transactions Review Committee, Member of the Strategy (Investment Decision) Committee, Member of the Nomination and Remuneration Assessment Committee, Audit Committee Members
  • 71.40K
  • zhenguo chai
  • Independent directors, Audit Committee Members, Member of the Nomination and Remuneration Assessment Committee, Chairman of the Related Transactions Review Committee, Member of the Strategy (Investment Decision) Committee
  • 71.40K
  • guangcheng pan
  • Independent directors, Member of the Strategy (Investment Decision) Committee, Audit Committee Members, Member of the Related Transactions Review Committee, Member of the Nomination and Remuneration Assessment Committee
  • 71.40K
  • jigang xie
  • Independent directors, Chairman of the Audit Committee, Member of the Strategy (Investment Decision) Committee, Member of the Related Transactions Review Committee, Member of the Nomination and Remuneration Assessment Committee
  • 71.40K
  • jing yang
  • Securities Affairs Representative
  • --
  • wei lv
  • Chairman of the Supervisory Board, Auditors
  • 355.50K
  • lijun yang
  • Auditors
  • --
  • wenzan gao
  • Auditors
  • --
  • rongliang liu
  • Deputy General Manager
  • --
  • min zhang
  • Deputy General Manager
  • --
  • zhigang duan
  • Deputy General Manager
  • --
  • tingde zhang
  • General Counsel
  • 766.90K
  • suoqing zhang
  • Employee Supervisors
  • 326.30K
  • fan li
  • Employee Supervisors
  • 322.30K